David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
CALL
ICU Medical
ICUI
$4.56B
| $1.15M | ﹤0.01% |
3,900
-200
| -5% | -$54.7K |
|
|
DVAX
2577
CALL
DELISTED
Dynavax Technologies
DVAX
| $1.14M | ﹤0.01% |
+75,000
| New | +$1.3M |
|
|
BZUN
2578
Baozun
BZUN
$165M
| $1.14M | ﹤0.01% |
+20,904
| New | +$1.11M |
|
2579
Natural Health Trends
NHTC
$15.1M
| $1.14M | ﹤0.01% |
45,704
-6,007
| -12% | -$126K |
|
2580
CALL
Wyndham Hotels & Resorts
WH
$5.63B
| $1.14M | ﹤0.01% |
+19,400
| New | +$1.19M |
|
2581
Rocket Pharmaceuticals
RCKT
$415M
| $1.13M | ﹤0.01% |
57,750
-81,450
| -59% | -$1.54M |
|
|
SFS
2582
DELISTED
Smart & Final Stores, Inc.
SFS
| $1.13M | ﹤0.01% |
204,407
+67,675
| +49% | +$342K |
|
2583
PUT
Alnylam Pharmaceuticals
ALNY
$32.1B
| $1.13M | ﹤0.01% |
11,500
-4,500
| -28% | -$446K |
|
2584
PUT
Hubbell
HUBB
$24.5B
| $1.13M | ﹤0.01% |
+10,700
| New | +$1.18M |
|
|
WUBA
2585
CALL
DELISTED
58.com Inc
WUBA
| $1.13M | ﹤0.01% |
16,300
| – | – |
|
|
DPLO
2586
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $1.13M | ﹤0.01% |
44,223
-215,160
| -83% | -$5.02M |
|
|
KEM
2587
PUT
DELISTED
KEMET Corporation
KEM
| $1.13M | ﹤0.01% |
46,800
+25,500
| +120% | +$519K |
|
|
EDR
2588
DELISTED
Education Realty Trust Inc
EDR
| $1.12M | ﹤0.01% |
27,107
-221,619
| -89% | -$7.9M |
|
2589
PUT
Alexandria Real Estate Equities
ARE
$9.1B
| $1.12M | ﹤0.01% |
8,900
| – | – |
|
2590
Pan American Silver
PAAS
$22.5B
| $1.12M | ﹤0.01% |
62,747
+22,953
| +58% | +$396K |
|
2591
Greenlight Captial
GLRE
$505M
| $1.12M | ﹤0.01% |
78,932
-11,485
| -13% | -$175K |
|
2592
CALL
Digital Realty Trust
DLR
$71.2B
| $1.12M | ﹤0.01% |
10,000
| – | – |
|
|
NPKI
2593
NPK International
NPKI
$1.12B
| $1.11M | ﹤0.01% |
102,779
-19,979
| -16% | -$203K |
|
2594
CALL
Mohawk Industries
MHK
$9.06B
| $1.11M | ﹤0.01% |
+5,200
| New | +$1.14M |
|
2595
NewMarket
NEU
$8.56B
| $1.11M | ﹤0.01% |
+2,753
| New | +$1.08M |
|
2596
Simpson Manufacturing
SSD
$7.65B
| $1.11M | ﹤0.01% |
17,877
-456
| -2% | -$27.7K |
|
2597
T. Rowe Price
TROW
$24.1B
| $1.11M | ﹤0.01% |
9,571
-24,001
| -71% | -$2.79M |
|
|
NBIS
2598
CALL
Nebius Group N.V.
NBIS
$60.3B
| $1.11M | ﹤0.01% |
+30,800
| New | +$1.07M |
|
|
CAI
2599
DELISTED
CAI International, Inc.
CAI
| $1.11M | ﹤0.01% |
47,604
-129,287
| -73% | -$3M |
|
|
FBR
2600
DELISTED
Fibria Celulose Sa
FBR
| $1.1M | ﹤0.01% |
59,459
-29,371
| -33% | -$565K |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.